This study was undertaken to investigate the influence of beta 2-glycoprotein I (GPI) on anticardiolipin antibody (aCL) titration in leprosy. The study group consisted of 140 sera from patients with multibacillary leprosy (46 borderline, 94 lepromatous). The group included newly diagnosed, previously untreated patients, patients under treatment and patients released from treatment. GPI addition enhanced significantly the aCL titres in sera from lepromatous leprosy but not in those from borderline leprosy. Moreover, when the patients were classified according to their bacteriological status, aCL titres were found to be significantly higher in skin smear positive patients compared to bacteriologically negative patients. Thus, the present stud...
The seroprevalence rates of IgM anti-phenolic glycolipid-I (PGL-I) antibodies in four study groups w...
Background: Contacts of leprosy patients are at increased risk of developing leprosy and need to be ...
The seroprevalence rates of IgM anti-phenolic glycolipid-I (PGL-I) antibodies in four study groups w...
2 glycoprotein I (2GPI) is a phospholipid binding protein that plays an important role in endothelia...
Antiphospholipid antibodies, such as anti-beta 2-glycoprotein I (beta 2GPI), are present in multibac...
BACKGROUND - Multibacillary (MB) leprosy may be manifested with antiphospholipid antibodies (aPL), a...
Serum IgM and IgG antibodies against Mycobacterium leprae-derived phenolic glycolipid I (PG) were de...
Objectives: To determine the prevalence of anticardiolipin (aCL) and anti-beta(2)-glycoprotein I (an...
A serological study was performed in 122 individuals: 75 leprosy patients and 47 healthy controls. T...
Leprosy inflammatory episodes [type 1 (T1R) and type 2 (T2R) reactions] represent the major cause of...
The suitability of IgM antibodies to PGL-1 for monitoring the response to multidrug therapy (MDT) wa...
Circulating immune complexes (CIC) were assayed in sera of leprosy patients. Using an immunoassay fo...
A simple serodiagnostic test based on the Mycobacterium leprae-specific phenolic glycolipid I(PGL-I)...
A simple serodiagnostic test based on the Mycobacterium leprae-specific phenolic glycolipid I(PGL-I)...
Despite elimination efforts, the number of Mycobacterium leprae (M. leprae) infected individuals who...
The seroprevalence rates of IgM anti-phenolic glycolipid-I (PGL-I) antibodies in four study groups w...
Background: Contacts of leprosy patients are at increased risk of developing leprosy and need to be ...
The seroprevalence rates of IgM anti-phenolic glycolipid-I (PGL-I) antibodies in four study groups w...
2 glycoprotein I (2GPI) is a phospholipid binding protein that plays an important role in endothelia...
Antiphospholipid antibodies, such as anti-beta 2-glycoprotein I (beta 2GPI), are present in multibac...
BACKGROUND - Multibacillary (MB) leprosy may be manifested with antiphospholipid antibodies (aPL), a...
Serum IgM and IgG antibodies against Mycobacterium leprae-derived phenolic glycolipid I (PG) were de...
Objectives: To determine the prevalence of anticardiolipin (aCL) and anti-beta(2)-glycoprotein I (an...
A serological study was performed in 122 individuals: 75 leprosy patients and 47 healthy controls. T...
Leprosy inflammatory episodes [type 1 (T1R) and type 2 (T2R) reactions] represent the major cause of...
The suitability of IgM antibodies to PGL-1 for monitoring the response to multidrug therapy (MDT) wa...
Circulating immune complexes (CIC) were assayed in sera of leprosy patients. Using an immunoassay fo...
A simple serodiagnostic test based on the Mycobacterium leprae-specific phenolic glycolipid I(PGL-I)...
A simple serodiagnostic test based on the Mycobacterium leprae-specific phenolic glycolipid I(PGL-I)...
Despite elimination efforts, the number of Mycobacterium leprae (M. leprae) infected individuals who...
The seroprevalence rates of IgM anti-phenolic glycolipid-I (PGL-I) antibodies in four study groups w...
Background: Contacts of leprosy patients are at increased risk of developing leprosy and need to be ...
The seroprevalence rates of IgM anti-phenolic glycolipid-I (PGL-I) antibodies in four study groups w...